Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / COM CL A NEW
-
Total 13F shares
-
292,531
-
Share change
-
+202,281
-
Total reported value
-
$1,842,955
-
Price per share
-
$6.30
-
Number of holders
-
14
-
Value change
-
+$1,826,377
-
Number of buys
-
13
-
Number of sells
-
1
Institutional Holders of P3 Health Partners Inc. - COM CL A NEW (PIII) as of Q2 2025
As of 30 Jun 2025,
P3 Health Partners Inc. - COM CL A NEW (PIII) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
292,531 shares.
The largest 10 holders included
Alyeska Investment Group, L.P., VANGUARD GROUP INC, Corient Private Wealth LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., BLAIR WILLIAM & CO/IL, UBS Group AG, PNC Financial Services Group, Inc., JPMORGAN CHASE & CO, and MORGAN STANLEY.
This page lists
14
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.